Medtronic's Enrolls 1st Patient in Parkinson's Disease Study
Medtronic said the ADAPT-PD study will look at the safety and efficacy of the use of adaptive deep brain stimulation in patients with Parkinson’s Disease.
Stay updated with breaking news from Brain Modulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medtronic said the ADAPT-PD study will look at the safety and efficacy of the use of adaptive deep brain stimulation in patients with Parkinson’s Disease.
Medtronic unveils adaptive deep brain stimulation trial in Parkinson's patients Medtronic unveils adaptive deep brain stimulation trial in Parkinson's patients 15 January 2021 | News The randomised study will take place across 12 study sites at leading movement disorders research centers in the US, Europe, and Canada Source: medtronic.com Medtronic plc, the global leader in medical technology, announced the first enrolment in ADAPT-PD (Adaptive DBS Algorithm for Personalised Therapy in Parkinson's Disease), its trial evaluating the safety and efficacy of adaptive deep brain...
Parkinson's Disease), its trial evaluating the safety and efficacy of adaptive deep brain stimulation (aDBS) in patients with Parkinson's Disease (PD). Adaptive deep brain stimulation is an investigational feature of the Percept™ PC device that could be enabled if approved. The investigational feature used in this study allows for automated adjustment of brain stimulation to provide therapy to manage symptoms of Parkinson's disease based on a patient's clinical state. The randomized study will take place across 12 study sites at leading Movement Disorders research centers in the United S...